The Future of Healthcare (1/21/15): Lead Participants

While The Future of X think tank sessions know no designated panelists, we invite seasoned and fresh innovators, entrepreneurs who are currently monetizing the changing landscape, marketers and representatives from within the industry as well as investors who provide the capital that moves the needle to serve as featured lead participants. Find a frequently updated list of our lead participants below. (If you want to sign up for the event, please do so here.)

  • Stephanie Cion is the principal at Cion Consult. The serial entrepreneur is incredibly passionate about health and technology. Stephanie has over fifteen years of experience in the healthcare industry at the nexus between healthcare and technology. She has developed a unique expertise and perspective working in a variety of capacities including; as a venture capitalists, creating strategy for industry stalwarts including Aetna, as well as having been involved with numerous start­up ventures at different stages of development! Stephanie attended The Dalton School, The George Washington University and New York University’s graduate program for Healthcare Finance and Policy.
  • Richard DeSimone is the Managing Partner of Roxiticus Ventures specializing in heathcare and technology.  Mr. DeSimone is a serial entrepreneur with multiple business successes including EKR Therapeutics, a Pharmaceutical company, sold to Chiesi, USA in 2012.  He currently serves on the board of Hackensack University Medical Center. He previously served as Chairman of HUMC’s Advisory Board.  Mr. DeSimone has served for 40 years as an executive and director in healthcare and technology businesses. He was honored as NJ’s CFO of the Year in 2010.   He currently serves board member of P4 health network developer CarpeVITA, Inc. and CVGenomics.
  • Deborah Estrin, PhD, is a Professor of Computer Science at Cornell Tech and co-founder of Open mHealth. Her current focus is on mobile health and small data, leveraging the pervasiveness of mobile devices and digital interactions for health and life management (TEDMED). Estrin was the founding director of the NSF-funded Science and Technology Center for Embedded Networked Sensing (CENS) at UCLA (2002-12). Awards include: ACM Athena Lecturer (2006), Anita Borg Institute’s Women of Vision Award for Innovation (2007). Member of American Academy of Arts and Sciences (2007), National Academy of Engineering (2009). PhD, MIT (1985); BS, UCB (1980)
  • Elizabeth Golluscio, co-founder and CEO of Altah Net. Elizabeth founded Altah Net, a digital platform for integrative primary care, after a career in sales, marketing and product management with software start-ups.  After painful experiences with conventional medicine and payer reimbursement debacles, she wanted to apply her professional skills in technology and marketing to her personal passion for health education, wellness, and self-care.   She holds an Engineering degree from Cornell and an MBA from MIT Sloan.  Connect with her @egolluscio.
  • Adam Griff is COO of Medstartr, the only company with a unique funding and engagement platform that combines the power of crowdfunding and crowdsourcing to guide healthcare startups from idea to successful exit. Previously, he co-founded Sarahcare, a comprehensive aging in place solution focused on post-acute and chronic care management, that he grew from a presence in two markets to fifteen.  Originally trained as a designer (Course IV at MIT), Adam uses his background in design thinking in creating new healthcare business models and strategies.
  • Dr. Karin Hehenberger, MD, PhD is CEO and founder of Lyfebulb. She is a leading medical and business expert in the biopharmaceutical industry and has more than 15 years experience in leadership positions at JNJ, Eyetech Pharmaceuticals, Coronado Biosciences, and also as an investment professional at two large funds, Brummer & Partners and Scandinavian Life Sciences Ventures. Her dedication to diabetes is reflected by her time on the senior team at the JDRF and conducting her post-doctorate at the Joslin Diabetes Center, Harvard Medical School. She received her MD and PhD at the Karolinska Institute in Stockholm, Sweden, where she retains a position with the Department of Endocrinology and Surgery.
  • Julie Holley is the Founder of Right Hook whose Wearable solution provides an ergonomic, self-powered, cross-platform device for use among Physicians and Patients.  Upon adoption/use the necessity of charging communicators externally will be eliminated. Her Wearable solution was derived from her unique point of view as an upper extremity amputee, her knowledge of nano-materials and her association with the Behavioral Working Group at the USC Center for Veterans and Military Families. Prior to her current work, she has been a Technologist and Technology Journalist.  She studied Journalism at Columbia University and graduated from Mount Holyoke College in 1987.
  • Fard Johnmar is the Founder and President of the Digital Health Innovation Consultancy Enspektos, LLC. Fard Johnmar is a digital health futurist and bestselling author who has been recognized for helping the health industry understand how digital health technologies have influenced the activities, perceptions and beliefs of customers, medical professionals and others. He is co-author of ePatient 2015: 15 Surprising Trends Changing Healthcare, which explores how health technologies are shaping the future of how consumers, caregivers and others will think about and receive care.
  • Srdjan “Serge” Loncar is founding president and CEO of CareSpeak. Serge started CareSpeak guided with the belief that the mobile phone, the most personal accessory, will play an increasingly important role in managing one’s health. Prior to starting CareSpeak, Serge was the President of Songbird Hearing, the manufacturer and marketer of the first disposable over-the-counter hearing aid. Before that he headed up strategic business development at that was acquired by Bertelsmann AG. In his pre-entrepreneurial life Serge held numerous domestic and international brand marketing and sales positions at Johnson & Johnson health care and medical device divisions, and Pepsi Cola International. Serge received his MBA from New York University’s Stern Business School.
  • Hugh Ma is a co-founder and Managing Partner at CIEN Ventures, a firm built on the thesis that early-stage healthcare companies face unique challenges, ranging from complex technical integrations, entrenched (and, let’s be honest, old-school) stakeholder mentalities, and excruciating sales cycles. Previously, Hugh was Head of Strategy and Innovation at Healthagen, a division of Aetna that offers HIT services to providers, payers, employers, and consumers.  Prior to Healthagen, Hugh was a Principal at Booz & Co and Diamond Technology (both acquired by PWC) and focused on the intersection of payers and providers.
  • Jean-Luc (“JL”) Neptune is currently Executive Director and manager of the Accelerator program Blueprint Health. Prior to his current role, the physician, innovator, technologist, and entrepreneur was Senior Vice President at Health 2.0 and Director of the Health 2.0 Developer Challenge program. JL co-founded two digital health startups in New York City including Healogica, an online clinical trials matching platform, and ExpertConsensus, a virtual second opinion service. JL is an investor in a number of web-based ventures and serves as a formal and informal advisor to more than a dozen digital health start-ups.
  • Richard A. Robbins, Therap Services CEO, co- founder. The unique combination of experiences Richard brings to the company is critical to its success serving the developmental disabilities community. In addition to founding and managing several successful technology-based companies, he has a direct operational understanding of developmental disabilities providers. He earned a Bachelor’s in Economics from Brandeis and MBA from Harvard School of Business, and was an investment banker before becoming an independent financial advisor, investor, founder, and manager of a number of companies heavily dependent on large-scale, highly secure and reliable technical systems. He is also on the board of the Genetic Disease Foundation at Mount Sinai School of Medicine.
  • Bob Schulz, General Partner and Co-Founder, Health Enterprise Partners and CB Health Ventures. Bob has been investing in innovative healthcare information technology companies since 1997 when he co-founded CB Health Ventures and its successor fund, Health Enterprise Partners.  At HEP (, he works with 23 of the largest hospital systems and health plans that are investors in HEP to identify, evaluate, fund and grow healthcare information technology companies that are transforming the delivery of healthcare.   Entrepreneurs embrace the access that HEP provides to its LPs which are very substantial potential customers for their innovative solutions.  HEP’s LPs include Cleveland Clinic, Intermountain Healthcare, Sutter Health, Dignity Health, Humana, Cigna, Horizon, Highmark, etc.
  • Simon Schurr, CEO and Chairman of Collaborative Medical Technology Corporation (CMT Corp) has over twenty five years of technology innovation and entrepreneurial experience, and has focused the last ten years on building transformational global healthcare technology solutions. Simon’s expertise is in business development, operational direction, project management, marketing, sales; he starts, invests and engages in companies focused on global medicine, remote and Telehealth applications, medical tourism, and doctors. Simon founded CMT Corp to enable “medicine without boundaries” using a solutions suite – the “Physician Collaboration Platform” – to securely collaborate. Simon holds an M.S. from Lehigh University, and a B.A. from the Hebrew University.
  • Stacey Seltzer, Partner, Aisling Capital. Ms. Seltzer joined Aisling in 2008 and currently serves as a Partner. Previously, Ms. Seltzer was at Schering-Plough, where she held roles in business development, marketing and sales. Prior to Schering-Plough, Ms. Seltzer was the Director of Business Development for Akceli, a biotechnology company developing cell-based microarrays, and she began her career as a management consultant for McKinsey & Company.  Ms. Seltzer serves as a director of Miramar Labs and previously served as a Board observer for Agile Therapeutics, Durata Therapeutics and ZELTIQ Aesthetics. Ms. Seltzer received her M.B.A. from The Wharton School at the University of Pennsylvania, and received her M.S. and B.S. from Yale University, awarded cum laude in Molecular Biophysics and Biochemistry.
  • Dr. William Sherman is an oncologist with a focus on both pancreatic cancer and autoimmune neurological disorders. His recent success, published in CANCER, illustrates the protocol he developed increases a patients three year survival rate by over 18%. Dr. Sherman has vast experience evaluating medical data from office records, hospital records, institutional clinical trials and national clinical trials. During the 1980’s he developed COMTRAC, a computer based medical tracking system, which employed graphical displays to assist the clinician in assessing treatment of each individual patient. Dr. Sherman continues to display a keen interest in how evolving technologies can assist doctors in evaluating medical data to help improve patient outcomes.
  • Stephen P. Squinto, Ph.D. is Venture Partner at OrbiMed. Dr. Squinto has recently joined OrbiMed in New York as a venture partner. Prior to this Dr Squinto was a co-founder of Alexion Pharmaceuticals, Inc. and served as a Corporate Officer since August 2000. At Alexion, Dr. Squinto was the Executive Vice President and Chief Global Operations Officer, was a member of the Executive Steering Committee and was responsible for Global Manufacturing, Quality and Project Management. Prior to 2013 he was the Global Head of Research and Development, a position he has held since 2007 where he was responsible for Clinical Development, Medical Affairs, Regulatory Affairs, Pharmacovigilence, Drug Discovery, Translational Medicine and Portfolio Management.
  • Robert Stern, MA is the founder and CEO of @Point of Care, decision-making mobile platform for HCP’s..and a StartUp Health company. Stern is also the founder and CEO of MedPage Today, acquired by Everyday Health in 2010, and serves on the advisory board. Stern was the president of,; and co-founder of Fingertip Formulary.  In 2009, Stern was named one of the 100 most inspiring and influential people in life sciences by Stern received a BFA from the New York University Tisch School of the Arts and a master’s degree in education from New York University.
  • Unity Stoakes, Co-founder and President at StartUp Health. Unity is the President of StartUp Health, a global startup platform to accelerate health and wellness innovation.  StartUp Health is creating a new model for helping startups grow and scale in the health sector and is helping build 1,000 digital health companies by 2020.  The company provides health and wellness innovators with a structured curriculum, access to customers, and peer support designed to help navigate the unique challenges of building a sustainable growth business.  Learn more at or connect @unitystoakes.

  • Eric Vieira, PhD is the Director of Special Research Programs for the City University of New York (CUNY) and the Bioscience Leader for the Bio & Health Tech Entrepreneurship Lab of NYC (ELabNYC). Eric is an economic catalyst and innovation explorer who has built a career at the interface of academia and industry helping to move ideas from discovery to commercialization. He has worked with numerous life scientists, medical specialists and independent entrepreneurs to foster innovation, accelerate technology development and launch companies. At CUNY, he is responsible for science workforce development efforts and helping to align educational training with industry needs. Eric is deeply rooted in New York’s bioscience ecosystem and is a Board Member of the MIT Enterprise Forum of New York City. He received his PhD in Developmental Genetics from NYU in 2003 and has worked on Wall Street as a biotech/pharm analyst.

The event page and signup form are at

Qualified attendees are invited to introduce themselves to the organizers so that they can be considered as lead participants. Please email to with the subject “Think Tank Participation,” and include(a) your name and title/company and (b) short blurb on your background as it relates to this topic (please keep it at 100 words), as well as any other comments to the organizers on your interests.

Attendance is limited to facilitate a highly engaged discussion. If registration has been closed, some reserved places for highly qualified participants may still be available.

We will update this page with our lead participants. Have a look at our lead participants from past events: The Future of Television, The Future of Advertising, The Future of Retail.


One thought on “The Future of Healthcare (1/21/15): Lead Participants

  1. […] The Future of Healthcare. (January 2015) — List of Lead Participants. […]

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: